However, other preclinical data, primarily obtained from cell lines, have suggested that epoetin may diminish the effects of cytostatic agents or promote tumour cell growth in vitro (Acs et al, 2003; Farrell and Lee, 2004). This evidence concerns the gene EPO and neoplasm.